Home/Filings/4/0001209191-22-032581
4//SEC Filing

FIELDS HEIDI 4

Accession 0001209191-22-032581

CIK 0001783183other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 4:43 PM ET

Size

5.7 KB

Accession

0001209191-22-032581

Insider Transaction Report

Form 4
Period: 2022-05-25
KUNZ HEIDI
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-25+15,00015,000 total
    Exercise: $7.40Exp: 2032-05-24Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1
  • filerCIK 0001014330

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:43 PM ET
Size
5.7 KB